327 filings
Page 5 of 17
8-K
a8vm2iamtfu9rzs0t6l9
26 Sep 19
Entry into a Material Definitive Agreement
9:07am
8-K
fqin9h7s
13 Sep 19
Entry into a Material Definitive Agreement
9:01am
8-K
axk8b85q6 vz0rao5
8 Aug 19
Ziopharm Oncology Reports Second Quarter 2019
8:00am
8-K
lkvag dgve
1 Aug 19
Ziopharm Oncology Announces $45 Million
4:31pm
8-K
ucokupmyp0o
24 Jul 19
Unregistered Sales of Equity Securities
8:39am
8-K
oqf0ejad
3 Jul 19
Ziopharm Oncology Names NCI’s Dr. Drew Deniger to
8:42am
8-K
xrrpwp94
27 Jun 19
Regulation FD Disclosure
4:31pm
8-K
oijwj7sy s89mq0a0h
26 Jun 19
Regulation FD Disclosure
8:35am
8-K
yn5u2j8jho8gt9woo5h
17 Jun 19
Departure of Directors or Certain Officers
4:31pm
8-K
xlr wb1421amaf
28 May 19
Entry into a Material Definitive Agreement
4:26pm
8-K
bda4y sij47q31grrw
8 May 19
Ziopharm Oncology Reports First Quarter 2019 Financial Results and Reaffirms Clinical Timelines
4:11pm
8-K
dj1wga5p qpxj
29 Apr 19
Departure of Directors or Certain Officers
4:42pm
8-K
w4l0k hpc
5 Mar 19
Ziopharm Oncology Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
4:10pm
8-K
ewqef
4 Feb 19
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:30pm
8-K
wer9y1t
10 Jan 19
Departure of Directors or Certain Officers
8:30am
8-K
oxsxfwqaj2y16swaj0we
7 Jan 19
Regulation FD Disclosure
4:20pm
8-K
mnehi9u3
14 Dec 18
Departure of Directors or Certain Officers
8:30am
8-K
qv3m t5w06au70d
13 Nov 18
Ziopharm Oncology Announces $50 Million Private Placement
8:39am
8-K
576ppf6fvyabpj6
16 Oct 18
Ziopharm Oncology Announces Changes to Board of Directors and Management Team
4:30pm
8-K
1jnu0mlmmmas hbjzr
11 Oct 18
Entry into a Material Definitive Agreement
9:05am